sulfadiazine has been researched along with Allergic Encephalomyelitis in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, ML | 1 |
| Li, WX | 1 |
| Wang, XY | 1 |
| Wu, YL | 1 |
| Chen, XF | 1 |
| Zhang, H | 1 |
| Yang, LQ | 1 |
| Wu, CZ | 1 |
| Zhang, SQ | 1 |
| Chen, YL | 1 |
| Feng, KR | 1 |
| Wang, B | 1 |
| Niu, L | 1 |
| Kong, DX | 1 |
| Tang, JF | 1 |
1 other study available for sulfadiazine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
Topics: Animals; Blood-Brain Barrier; Dysbiosis; Encephalomyelitis, Autoimmune, Experimental; Gastrointestin | 2022 |